Skip to main content
SSO 2026 Annual Meeting Main banner

Breast

CME

Breast Great Debate

Thursday, March 5, 2026
8:55 AM - 9:55 AM MST
Location:301D
CE: 1

In the era of de-escalation and precision oncology, breast surgeons often face pressure to adopt practice-changing evidence as soon as it is published — sometimes before long-term outcomes are known. Is this in the best interest of our patients?

Learning Objectives:

  • Present findings from recent, important clinical trials in breast surgery.
  • Determine whether recent clinical trial data supports changes in clinical practice.
  • Critically examine the evidence for/against the merits of further study into eliminating surgery for exceptional responders after neoadjuvant chemotherapy.

Presentations:

  • 8:55 AM - 8:58 AM MST
    Introduction to Debate #1
  • 8:58 AM - 9:08 AM MST
    Debate #1: When Clinical Trials Answer Only One Piece of the Puzzle: How Should Multidisciplinary Teams Implement Partial Evidence in Locoregional Breast Cancer Management - PRO

    Faculty: Monica Morrow, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

  • 9:08 AM - 9:18 AM MST
    Debate #1: When Clinical Trials Answer Only One Piece of the Puzzle: How Should Multidisciplinary Teams Implement Partial Evidence in Locoregional Breast Cancer Management - CON

    Faculty: Simona F. Shaitelman, MD, EdM (she/her/hers) – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA

  • 9:18 AM - 9:20 AM MST
    Debate #1: Rebuttal - PRO

    Faculty: Monica Morrow, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

  • 9:20 AM - 9:22 AM MST
    Debate #1: Rebuttal – CON

    Faculty: Simona F. Shaitelman, MD, EdM (she/her/hers) – Department of Breast Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA

  • 9:22 AM - 9:24 AM MST
    Introduction to Debate #2
  • 9:24 AM - 9:31 AM MST
    Debate # 2: Should pCR Allow us to Omit Surgery? - PRO

    Faculty: Helen M. Johnson, MD, IBCLC (she/her/hers) – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center

  • 9:31 AM - 9:38 AM MST
    Debate # 2: Should pCR Allow us to Omit Surgery? - CON

    Faculty: Irene Wapnir, MD – Stanford University School of Medicine

  • 9:38 AM - 9:40 AM MST
    Debate # 2: Rebuttal - PRO

    Faculty: Helen M. Johnson, MD, IBCLC (she/her/hers) – Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center

  • 9:40 AM - 9:42 AM MST
    Debate # 2: Rebuttal – CON

    Faculty: Irene Wapnir, MD – Stanford University School of Medicine

  • 9:42 AM - 9:52 AM MST
    Q&A